Paris, France

Sandrine Biscarrat


 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Paris, FR (2013 - 2014)
  • Gif sur Yvette, FR (2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Sandrine Biscarrat: Innovator in Cardiovascular Therapeutics

Introduction

Sandrine Biscarrat is a prominent inventor based in Paris, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of innovative compounds for treating cardiovascular diseases. With a total of 4 patents to her name, Biscarrat's work exemplifies the intersection of scientific research and practical application.

Latest Patents

Among her latest patents, Biscarrat has developed 5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases. This invention focuses on the therapeutic use of these derivatives, which are defined by a specific formula. Additionally, she has worked on cycloalkylamine substituted isoquinoline and isoquinolinone derivatives, which are useful for the treatment and prevention of diseases associated with Rho-kinase and its mediated phosphorylation of myosin light chain phosphatase.

Career Highlights

Throughout her career, Biscarrat has been associated with notable companies such as Sanofi and Sanofi-Aventis. Her work in these organizations has allowed her to contribute to the advancement of pharmaceutical research and development.

Collaborations

Some of her notable coworkers include Olivier Duclos and Gary McCort. Their collaborative efforts have further enhanced the impact of her inventions in the field.

Conclusion

Sandrine Biscarrat's innovative work in the development of therapeutic compounds showcases her dedication to improving cardiovascular health. Her contributions through patents and collaborations highlight her role as a leading inventor in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…